Taiwan · Delayed Price · Currency is TWD Bioteque Statistics
Total Valuation
Bioteque has a market cap or net worth of TWD 8.14 billion. The enterprise value is 7.08 billion.
| Market Cap | 8.14B |
| Enterprise Value | 7.08B |
Important Dates
The last earnings date was Thursday, March 12, 2026.
| Earnings Date | Mar 12, 2026 |
| Ex-Dividend Date | Jul 28, 2025 |
Share Statistics
Bioteque has 69.30 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Current Share Class | 69.30M |
| Shares Outstanding | 69.30M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | +0.51% |
| Owned by Insiders (%) | 4.21% |
| Owned by Institutions (%) | 3.98% |
| Float | 47.64M |
Valuation Ratios
The trailing PE ratio is 15.18 and the forward PE ratio is 14.47.
| PE Ratio | 15.18 |
| Forward PE | 14.47 |
| PS Ratio | 3.81 |
| PB Ratio | 2.26 |
| P/TBV Ratio | 2.26 |
| P/FCF Ratio | 13.41 |
| P/OCF Ratio | 12.26 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.41, with an EV/FCF ratio of 11.66.
| EV / Earnings | 13.13 |
| EV / Sales | 3.32 |
| EV / EBITDA | 8.41 |
| EV / EBIT | 10.56 |
| EV / FCF | 11.66 |
Financial Position
The company has a current ratio of 4.27, with a Debt / Equity ratio of 0.17.
| Current Ratio | 4.27 |
| Quick Ratio | 3.64 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 0.72 |
| Debt / FCF | 0.99 |
| Interest Coverage | 88.88 |
Financial Efficiency
Return on equity (ROE) is 15.30% and return on invested capital (ROIC) is 21.01%.
| Return on Equity (ROE) | 15.30% |
| Return on Assets (ROA) | 9.00% |
| Return on Invested Capital (ROIC) | 21.01% |
| Return on Capital Employed (ROCE) | 16.30% |
| Weighted Average Cost of Capital (WACC) | 4.72% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.46 |
| Inventory Turnover | 3.90 |
Taxes
In the past 12 months, Bioteque has paid 135.44 million in taxes.
| Income Tax | 135.44M |
| Effective Tax Rate | 20.08% |
Stock Price Statistics
The stock price has decreased by -7.09% in the last 52 weeks. The beta is 0.14, so Bioteque's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | -7.09% |
| 50-Day Moving Average | 120.66 |
| 200-Day Moving Average | 119.44 |
| Relative Strength Index (RSI) | 43.71 |
| Average Volume (20 Days) | 55,671 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bioteque had revenue of TWD 2.14 billion and earned 539.19 million in profits. Earnings per share was 7.74.
| Revenue | 2.14B |
| Gross Profit | 936.94M |
| Operating Income | 670.28M |
| Pretax Income | 674.62M |
| Net Income | 539.19M |
| EBITDA | 841.83M |
| EBIT | 670.28M |
| Earnings Per Share (EPS) | 7.74 |
Balance Sheet
The company has 1.67 billion in cash and 603.70 million in debt, with a net cash position of 1.06 billion or 15.34 per share.
| Cash & Cash Equivalents | 1.67B |
| Total Debt | 603.70M |
| Net Cash | 1.06B |
| Net Cash Per Share | 15.34 |
| Equity (Book Value) | 3.61B |
| Book Value Per Share | 52.04 |
| Working Capital | 1.79B |
Cash Flow
In the last 12 months, operating cash flow was 664.20 million and capital expenditures -57.20 million, giving a free cash flow of 607.00 million.
| Operating Cash Flow | 664.20M |
| Capital Expenditures | -57.20M |
| Depreciation & Amortization | 171.55M |
| Net Borrowing | -164.08M |
| Free Cash Flow | 607.00M |
| FCF Per Share | 8.76 |
Margins
Gross margin is 43.88%, with operating and profit margins of 31.39% and 25.25%.
| Gross Margin | 43.88% |
| Operating Margin | 31.39% |
| Pretax Margin | 31.59% |
| Profit Margin | 25.25% |
| EBITDA Margin | 39.42% |
| EBIT Margin | 31.39% |
| FCF Margin | 28.42% |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 4.20%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 4.20% |
| Dividend Growth (YoY) | 11.11% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 64.60% |
| Buyback Yield | -0.04% |
| Shareholder Yield | 4.20% |
| Earnings Yield | 6.62% |
| FCF Yield | 7.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 20, 2015. It was a reverse split with a ratio of 0.8006917977.
| Last Split Date | Aug 20, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.8006917977 |
Scores
Bioteque has an Altman Z-Score of 6.94 and a Piotroski F-Score of 8.
| Altman Z-Score | 6.94 |
| Piotroski F-Score | 8 |